Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies.
Danesh HassaniMahmood Jeddi-TehraniParisa YousefiSamaneh Mansouri-FardMaryam MobiniHengameh Ahmadi-ZareForough Golsaz-ShiraziMohammad Mehdi AmiriMohammad-Reza ShokriPublished in: Cancer chemotherapy and pharmacology (2022)
Some of the anti-HER3 MAbs produced in this study displayed tumor inhibitory function and may be considered promising candidates for future HER3-targeted cancer therapy.
Keyphrases